Analysis of the influence of polymer characteristics and core loading on the in vivo release of a somatostatin analogue

European Journal of Pharmaceutical Sciences

Volumn 5, Issue 6, 1997, Pages 303-313

  Rothen Weinhold, Alexandra ^a,b   Besseghir, Kamel ^c   Gurny, Robert ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b F 74166   (France)

^c DEBIOPHARM SA   (Switzerland)

Author keywords

Controlled release system; Extrusion; Peptide; Poly(D,L lactic co glycolic acid); Somatostatin analogue; Sterilization; Vapreotide

Indexed keywords

POLYGLACTIN; POLYMER; SOMATOSTATIN; VAPREOTIDE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED RELEASE FORMULATION; DRUG BLOOD LEVEL; DRUG RELEASE; GEL PERMEATION CHROMATOGRAPHY; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031282608     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)00022-5     Document Type: Article

References (42)

1. Asano, M., Fukuzaki, H., Yoshida, M., Kumakura, M., Mashimo, T., Yuasa, H., Imai, K, and Yamanaka, H. (1989) In vivo characteristics of low molecular weight copoly(D,L-lactic acid) formulations with controlled release of LH-RH agonist. Biomaterials 10, 559-573.
2. Aso, Y. Yoshioka, S., Otsuka, T. and Kojima, S. (1995) Effects of gamma-irradiation on the drug release characteristics of poly(D,L-lactide) microspheres. Proc. Int. Symp. Control. Rel. Bioact. Mater. 22, 386-387.
3. Athanasiou, K., Agrawal, C.M. and Niederauer, G.G. (1996) Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymers. Biomaterials 17, 93-102.
4. Bodmer, D., Kissel, T. and Traechslin, E. (1992) Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. J. Control. Rel. 21, 129-137.
5. Brinston, R.M. and Wilson, B.K. (1993) Converting to gamma-radiation sterilization: an overview for medical device manufacturers. Medical Device Technology, 13, 1-12.
6. Chu, C.C. (1981) Hydrolytic degradation of polyglycolic acid: tensile strength and crystallinity study. J. Appl. Polym. Sci. 26, 1727-1734.
7. Chu, C.C. (1985) Degradation phenomena of two linear aliphaticpolyester fibres used in medicine and surgery. Polymer 26, 591-594.
8. Cohn, D., Younes, H. and Marom, G. (1987) Amorphous and crystalline morphologies in glycolic acid and lactic acid polymers. Polymer 28, 2018-2022.
9. Gurtler, F., Kaltsatos, V., Boisramé, B. and Gurny, R. (1995) Long-acting soluble bioadhesive ophtalmie drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation. J. Control. Rel. 33, 231-236.
10. Heller, J. (1984) Biodegradable polymers in controlled drug delivery. In: Therapeutic drug carrier systems. CRC Press, Boca Raton.
11. Heya, T., Okada, H., Ogawa, Y. and Toguchi, H. (1991) Factors influencing the profiles of TRH release from copoly(D,L-lactic/glycolic acid) microspheres. Int. J. Pharm. 72, 199-205.
12. Holland, S.J., Tighe, BJ. and Gould, P.L. (1986) Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecular release systems. J. Control. Rel. 4, 155-180.
13. Hutchinson, F.G. and Furr, B.J.A. (1985) Biodegradable polymers for the sustained release of peptides. Biochem. Soc. Trans. 13, 520-523.
14. Jalil, R. and Nixon, J.R. ( 1990) Microencapsulation using poly (D,L-lactic acid) III: effect of polymer molecular weight on the release kinetics. J. Microencapsulation 7(3), 357-374.
15. Jamshidi, K., Hyon, S.-H. and Ikada, Y. (1988) Thermal characterization of polylactides. Polymer 29, 2229-2234.
16. Kitchell, J.P. and Wise, D.L. (1985) Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems. Methods Enzymol. 112, 436-448.
17. Lamberts, S.W.J., Van Der Lely, A.-J., De Herder, W.W., Hofland, L.J., (1996) Octreotide, N. Engl. J. Med. 334(4), 246-254.
18. Li, S.M., Carreau, H. and Vert, M. (1990) Structure-property relationships in the case of the degradation of massive poly(alpha-hydroxy acids) in aqueous media. J. Mater. Sci. Mater. Med. 1, 131-139.
19. Lim, L.Y., Gould, P., Dickinson, N.A. and Collett, J.H. (1988) The influence of environmental conditions on damage in L-polylactic acid during gamma-irradiation. Proc. Int. Symp. Control. Rel. Bioact. Mater. 15, 111-112.
20. Merkli, A., Heller, J., Tabatabay, C. and Gurny, R. (1994) Gamma sterilization of a semi-solid poly(ortho ester) designed for controlled drug delivery-validation and radiation effects. Pharm. Res. 11, 1485-1491.
21. Niwa, T., Takeuchi, H., Hino, T., Nohara, M. and Kawashima, Y. (1995) Biodegradable submicron carriers for peptide drugs: preparation of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate by a novel emulsion-phase separation method in an oil system. Int. J. Pharm. 121, 45-54.
22. Okada, H., Heya, T., Ogawa, Y. and Shimamoto, T. (1988) One-month release injectable microcapsules of a lutemizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats. J. Pharmacol. Exp. Ther. 244, 744-750.
23. Okada, H., Yamamoto, M., Heya, T., Inoue, Y., Kamei, S., Ogawa, Y. and Toguchi, H. (1994) Drug delivery using biodegradable microspheres. J. Control. Rel. 28, 121-129.
24. Park, T.G. (1994) Degradation of poly(D,L,-lactic acid) microspheres: effect of molecular weight. J. Control. Rel. 30, 161-173.
25. Park, T.G. (1995) Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials 16, 1123-1130.
26. Park, T.G., Lu, W. and Crotts, G. (1995) Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsuled poly(D,L-lactic acid-coglycolic acid) microspheres. J. Control. Rel. 33, 211-222.
27. Parmar, H., Phillips, R.H. and Lightman, S.L. (1993) Somatostatin analogues: mechanisms of action. Recent Results Cancer Res. 129, 1-24.
28. Pinski, J., Schally, A.V., Halmos, G. and Szepeshazi, K. (1993) Effect of somatostatin analog re-160 and bombesin/gastrin releasing peptide antagonist rc-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice. Int. J, Cancer 55, 963-967.
29. Plester, D.W. (1970) The effects of sterilising processes on plastics. Biomed. Eng. September 443-447.
30. Rafler, G. and Jobmann, M. (1994) Controlled release systems of biodegradable polymers. Drugs Made Ger. 37, 83-88.
31. Ruiz, J.M., Busnel, J.P. and Benoît, J.P. (1990) Influence of average molecular weights of poly(D,L-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres. Pharm. Res. 7(9), 928-934.
32. Sanders, L.M., Kell, B.A., McRae, G.I. and Whitehead, G.W. (1986) Prolonged controlled-release of nafareltn, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. J. Pharm. Sci. 75, 356-360.
33. Schindler, A. (1977) Contemporary topics in polymer science, Vol.2, Biodegradable polymers for sustained drug delivery. Plenum Press, New York and London.
34. Shah, S.S., Cha, Y. and Pitt, G.G. (1992) Poly(glycolic acid-co-D,L-lactic acid): diffusion or degradation controlled drug delivery?. J. Control. Rel. 18, 261-270.
35. Siegel, R.A. and Langer, R. (1984) Controlled release of polypeptides and other macromolecules. Pharm. Res. 1, 2-10.
36. Tracy, M.A., Firouzabadian, L. and Zhang, Y. (1995) Effects of PLGA end groups on degradation. Proc. Int. Symp. Control. Rel. Bioact. Mater. 22, 786-787.
37. Vert, M., Li, S. and Garreau, H. (1991) More about the degradation of LA/GA-derived matrices in aqueous media. J. Control. Rel. 16. 15-26.
38. Volland, C., Wolff, M. and Kissel, T. (1994) The influence of terminal gamma-sterilization on captopril containing poly(D,L-lactide-co-gly-colide) microspheres. J. Control. Rel. 31, 293-305.
39. Wang, H.T., Palmer, H., Linhardt, R.J., Flanagan, D.R. and Schmitt. E. (1990) Degradation of poly(ester) microspheres. Biomaterials 11, 679-685.
40. Weiler, W. and Gogolewski, S. (1996) Enhancement of the mechanical properties of polylactides by solid-state extrusion. I. Poly(D-lactide). Biomaterials 17, 529-535.
41. Wise, D.L., Fellmann, T.D., Sanderson, J.E. and Wentworth, R.L. (1979) Drug carriers in biology and medicine. Lactic/glycolic acid polymers. Academic Press, New York.
42. Zhang, X., Wyss, U.P., Pichora, D. and Goosen, M.F.A. (1994) A mechanistic study of antibiotic release from biodegradable poly(D,L-lactide) cylinders. J. Control. Rel. 31, 129-144.